HEADER IMMUNE SYSTEM 10-AUG-16 5SY8 TITLE CRYSTAL STRUCTURE OF THE COMPLEX OF 10E8 FAB LIGHT CHAIN MUTANT1 AND TITLE 2 T117V2 HIV-1 MPER SCAFFOLD COMPND MOL_ID: 1; COMPND 2 MOLECULE: 10E8 FAB HEAVY CHAIN; COMPND 3 CHAIN: H; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: 10E8 FAB LIGHT CHAIN; COMPND 7 CHAIN: L; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 3; COMPND 10 MOLECULE: 10E8 EPITOPE SCAFFOLD T117V2; COMPND 11 CHAIN: O; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_TAXID: 9606; SOURCE 4 GENE: IGHV3-15*05; SOURCE 5 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 7 EXPRESSION_SYSTEM_CELL_LINE: HEK 293S; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PHCMV3; SOURCE 10 MOL_ID: 2; SOURCE 11 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 12 ORGANISM_TAXID: 9606; SOURCE 13 GENE: IGLV3-19*01; SOURCE 14 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 15 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 16 EXPRESSION_SYSTEM_CELL_LINE: HEK 293S; SOURCE 17 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 18 EXPRESSION_SYSTEM_PLASMID: PHCMV3; SOURCE 19 MOL_ID: 3; SOURCE 20 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 21 ORGANISM_TAXID: 32630; SOURCE 22 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 23 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 24 EXPRESSION_SYSTEM_STRAIN: BL-21 STAR; SOURCE 25 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 26 EXPRESSION_SYSTEM_PLASMID: PET29 KEYWDS HIV-1 GP41 MPER, 10E8 FAB, LIPID MEMBRANE, IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR A.IRIMIA,I.A.WILSON REVDAT 4 04-OCT-23 5SY8 1 REMARK REVDAT 3 11-DEC-19 5SY8 1 REMARK REVDAT 2 20-SEP-17 5SY8 1 REMARK REVDAT 1 08-MAR-17 5SY8 0 JRNL AUTH A.IRIMIA,A.M.SERRA,A.SARKAR,R.JACAK,O.KALYUZHNIY,D.SOK, JRNL AUTH 2 K.L.SAYE-FRANCISCO,T.SCHIFFNER,R.TINGLE,M.KUBITZ,Y.ADACHI, JRNL AUTH 3 R.L.STANFIELD,M.C.DELLER,D.R.BURTON,W.R.SCHIEF,I.A.WILSON JRNL TITL LIPID INTERACTIONS AND ANGLE OF APPROACH TO THE HIV-1 VIRAL JRNL TITL 2 MEMBRANE OF BROADLY NEUTRALIZING ANTIBODY 10E8: INSIGHTS FOR JRNL TITL 3 VACCINE AND THERAPEUTIC DESIGN. JRNL REF PLOS PATHOG. V. 13 06212 2017 JRNL REFN ESSN 1553-7374 JRNL PMID 28225819 JRNL DOI 10.1371/JOURNAL.PPAT.1006212 REMARK 2 REMARK 2 RESOLUTION. 1.62 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.9_1692 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.62 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.49 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.970 REMARK 3 COMPLETENESS FOR RANGE (%) : 86.6 REMARK 3 NUMBER OF REFLECTIONS : 61470 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.174 REMARK 3 R VALUE (WORKING SET) : 0.172 REMARK 3 FREE R VALUE : 0.214 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 3075 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 40.4977 - 4.5354 0.91 2780 146 0.1545 0.1656 REMARK 3 2 4.5354 - 3.6006 0.84 2563 136 0.1394 0.1788 REMARK 3 3 3.6006 - 3.1457 0.90 2757 145 0.1598 0.1991 REMARK 3 4 3.1457 - 2.8582 0.93 2856 150 0.1809 0.2259 REMARK 3 5 2.8582 - 2.6533 0.82 2502 132 0.1830 0.2173 REMARK 3 6 2.6533 - 2.4969 0.89 2740 144 0.1931 0.2054 REMARK 3 7 2.4969 - 2.3719 0.90 2731 144 0.1895 0.2637 REMARK 3 8 2.3719 - 2.2687 0.91 2791 147 0.1793 0.2821 REMARK 3 9 2.2687 - 2.1813 0.89 2713 143 0.1817 0.2168 REMARK 3 10 2.1813 - 2.1061 0.80 2490 131 0.1766 0.2329 REMARK 3 11 2.1061 - 2.0402 0.87 2642 138 0.1732 0.2373 REMARK 3 12 2.0402 - 1.9819 0.88 2706 143 0.1760 0.2105 REMARK 3 13 1.9819 - 1.9297 0.89 2745 145 0.1776 0.2458 REMARK 3 14 1.9297 - 1.8826 0.89 2699 141 0.1776 0.2443 REMARK 3 15 1.8826 - 1.8398 0.90 2791 147 0.1787 0.2204 REMARK 3 16 1.8398 - 1.8007 0.83 2526 133 0.1844 0.2357 REMARK 3 17 1.8007 - 1.7647 0.83 2530 134 0.1980 0.2441 REMARK 3 18 1.7647 - 1.7314 0.85 2575 135 0.2013 0.2637 REMARK 3 19 1.7314 - 1.7004 0.86 2683 142 0.2187 0.2981 REMARK 3 20 1.7004 - 1.6716 0.87 2667 140 0.2379 0.2944 REMARK 3 21 1.6716 - 1.6447 0.85 2603 137 0.2399 0.2854 REMARK 3 22 1.6447 - 1.6193 0.76 2305 122 0.2516 0.3150 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.200 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 25.610 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 22.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.006 4904 REMARK 3 ANGLE : 1.032 6708 REMARK 3 CHIRALITY : 0.039 738 REMARK 3 PLANARITY : 0.005 883 REMARK 3 DIHEDRAL : 12.478 1752 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5SY8 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 11-AUG-16. REMARK 100 THE DEPOSITION ID IS D_1000223250. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-JUN-15 REMARK 200 TEMPERATURE (KELVIN) : 110 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL12-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97950 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 2.3.8 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 2.3.8 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 61518 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.619 REMARK 200 RESOLUTION RANGE LOW (A) : 40.490 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 86.9 REMARK 200 DATA REDUNDANCY : 3.500 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.08700 REMARK 200 FOR THE DATA SET : 9.0100 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.62 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.65 REMARK 200 COMPLETENESS FOR SHELL (%) : 82.0 REMARK 200 DATA REDUNDANCY IN SHELL : 2.80 REMARK 200 R MERGE FOR SHELL (I) : 0.71100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER 2.5.2 REMARK 200 STARTING MODEL: 4G6F, 3LF6 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.90 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.21 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M HEPES PH 7.5, 20% PEG 8000, REMARK 280 VAPOR DIFFUSION, TEMPERATURE 295.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6480 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 26500 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -40.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: H, L, O REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASP H 217 REMARK 465 SER L 1 REMARK 465 TYR L 2 REMARK 465 SER L 213 REMARK 465 ASN O 7 REMARK 465 ALA O 8 REMARK 465 MET O 9 REMARK 465 GLN O 10 REMARK 465 HIS O 166 REMARK 465 HIS O 167 REMARK 465 HIS O 168 REMARK 465 HIS O 169 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU H 1 CG CD OE1 OE2 REMARK 470 LYS H 43 CD CE NZ REMARK 470 LYS L 93 CD CE NZ REMARK 470 LYS L 130 CD CE NZ REMARK 470 LYS L 150 CD CE NZ REMARK 470 LYS L 157 CD CE NZ REMARK 470 GLU L 184 CG CD OE1 OE2 REMARK 470 LYS L 187 CD CE NZ REMARK 470 LYS O 24 CD CE NZ REMARK 470 GLU O 25 CG CD OE1 OE2 REMARK 470 GLU O 93 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO O 68 C - N - CA ANGL. DEV. = -10.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO H 100G 43.73 -95.09 REMARK 500 PHE L 48 144.78 -170.48 REMARK 500 ASN L 52 57.06 -163.92 REMARK 500 ASN L 52 33.27 -159.40 REMARK 500 SER L 90 -168.57 -164.78 REMARK 500 ASP L 152 -98.94 57.09 REMARK 500 PRO O 68 -73.72 -73.44 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL L 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL L 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL O 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL O 202 DBREF 5SY8 H 1 217 PDB 5SY8 5SY8 1 217 DBREF 5SY8 L 1 213 PDB 5SY8 5SY8 1 213 DBREF 5SY8 O 7 169 PDB 5SY8 5SY8 7 169 SEQRES 1 H 235 GLU VAL GLN LEU VAL GLU SER GLY GLY GLY LEU VAL LYS SEQRES 2 H 235 PRO GLY GLY SER LEU ARG LEU SER CYS SER ALA SER GLY SEQRES 3 H 235 PHE ASP PHE ASP ASN ALA TRP MET THR TRP VAL ARG GLN SEQRES 4 H 235 PRO PRO GLY LYS GLY LEU GLU TRP VAL GLY ARG ILE THR SEQRES 5 H 235 GLY PRO GLY GLU GLY TRP SER VAL ASP TYR ALA ALA PRO SEQRES 6 H 235 VAL GLU GLY ARG PHE THR ILE SER ARG LEU ASN SER ILE SEQRES 7 H 235 ASN PHE LEU TYR LEU GLU MET ASN ASN LEU ARG MET GLU SEQRES 8 H 235 ASP SER GLY LEU TYR PHE CYS ALA ARG THR GLY LYS TYR SEQRES 9 H 235 TYR ASP PHE TRP SER GLY TYR PRO PRO GLY GLU GLU TYR SEQRES 10 H 235 PHE GLN ASP TRP GLY ARG GLY THR LEU VAL THR VAL SER SEQRES 11 H 235 SER ALA SER THR LYS GLY PRO SER VAL PHE PRO LEU ALA SEQRES 12 H 235 PRO SER SER LYS SER THR SER GLY GLY THR ALA ALA LEU SEQRES 13 H 235 GLY CYS LEU VAL LYS ASP TYR PHE PRO GLU PRO VAL THR SEQRES 14 H 235 VAL SER TRP ASN SER GLY ALA LEU THR SER GLY VAL HIS SEQRES 15 H 235 THR PHE PRO ALA VAL LEU GLN SER SER GLY LEU TYR SER SEQRES 16 H 235 LEU SER SER VAL VAL THR VAL PRO SER SER SER LEU GLY SEQRES 17 H 235 THR GLN THR TYR ILE CYS ASN VAL ASN HIS LYS PRO SER SEQRES 18 H 235 ASN THR LYS VAL ASP LYS ARG VAL GLU PRO LYS SER CYS SEQRES 19 H 235 ASP SEQRES 1 L 215 SER TYR GLU LEU THR GLN GLU THR GLY VAL SER VAL ALA SEQRES 2 L 215 LEU GLY GLN THR VAL THR ILE THR CYS GLN GLY ASP SER SEQRES 3 L 215 LEU ARG SER HIS TYR ALA SER TRP TYR GLN LYS LYS PRO SEQRES 4 L 215 GLY GLN ALA PRO ILE LEU LEU PHE TYR GLY LYS ASN ASN SEQRES 5 L 215 ARG PRO SER GLY VAL PRO ASP ARG PHE SER GLY SER ALA SEQRES 6 L 215 SER GLY ASN THR ALA SER LEU THR ILE SER GLY ALA GLN SEQRES 7 L 215 ALA GLU ASP ASP ALA GLU TYR TYR CYS SER SER ARG ASP SEQRES 8 L 215 LYS SER GLY SER ARG LEU SER VAL PHE GLY GLY GLY THR SEQRES 9 L 215 LYS LEU THR VAL LEU SER GLN PRO LYS ALA ALA PRO SER SEQRES 10 L 215 VAL THR LEU PHE PRO PRO SER SER GLU GLU LEU GLN ALA SEQRES 11 L 215 ASN LYS ALA THR LEU VAL CYS LEU ILE SER ASP PHE TYR SEQRES 12 L 215 PRO GLY ALA VAL THR VAL ALA TRP LYS ALA ASP SER SER SEQRES 13 L 215 PRO VAL LYS ALA GLY VAL GLU THR THR THR PRO SER LYS SEQRES 14 L 215 GLN SER ASN ASN LYS TYR ALA ALA SER SER TYR LEU SER SEQRES 15 L 215 LEU THR PRO GLU GLN TRP LYS SER HIS ARG SER TYR SER SEQRES 16 L 215 CYS GLN VAL THR HIS GLU GLY SER THR VAL GLU LYS THR SEQRES 17 L 215 VAL ALA PRO THR GLU CYS SER SEQRES 1 O 163 ASN ALA MET GLN GLY ILE HIS PHE ARG ARG HIS TYR VAL SEQRES 2 O 163 ARG HIS LEU PRO LYS GLU VAL SER GLN ASN ASP ILE ILE SEQRES 3 O 163 LYS ALA LEU ALA SER PRO LEU ILE ASN ASP GLY MET VAL SEQRES 4 O 163 VAL SER ASP PHE ALA ASP HIS VAL ILE THR ARG GLU GLN SEQRES 5 O 163 ASN PHE PRO THR GLY LEU PRO VAL GLU PRO VAL GLY VAL SEQRES 6 O 163 ALA ILE PRO HIS THR ASP SER LYS TYR VAL ARG GLN ASN SEQRES 7 O 163 ALA ILE SER VAL GLY ILE LEU ALA GLU PRO VAL ASN PHE SEQRES 8 O 163 GLU ASP ALA GLY GLY GLU PRO ASP PRO VAL PRO VAL ARG SEQRES 9 O 163 VAL VAL PHE MET LEU ALA LEU GLY ASN TRP PHE ASP ILE SEQRES 10 O 163 THR ASN VAL LEU TRP TRP ILE LYS ALA VAL ILE GLN ASP SEQRES 11 O 163 GLU ASP PHE MET GLN GLN LEU LEU VAL MET ASN ASP ASP SEQRES 12 O 163 GLU ILE TYR GLN SER ILE TYR THR ARG ILE SER GLU LEU SEQRES 13 O 163 GLU HIS HIS HIS HIS HIS HIS HET GOL L 301 6 HET GOL L 302 6 HET GOL O 201 6 HET GOL O 202 6 HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 4 GOL 4(C3 H8 O3) FORMUL 8 HOH *351(H2 O) HELIX 1 AA1 ASP H 28 ALA H 32 5 5 HELIX 2 AA2 GLY H 52A GLY H 54 5 5 HELIX 3 AA3 ARG H 83 SER H 87 5 5 HELIX 4 AA4 SER H 127 LYS H 129 5 3 HELIX 5 AA5 SER H 156 ALA H 158 5 3 HELIX 6 AA6 SER H 187 LEU H 189 5 3 HELIX 7 AA7 LYS H 201 ASN H 204 5 4 HELIX 8 AA8 ASP L 26 SER L 30 5 5 HELIX 9 AA9 GLN L 79 ASP L 83 5 5 HELIX 10 AB1 SER L 122 ALA L 128 1 7 HELIX 11 AB2 THR L 182 HIS L 189 1 8 HELIX 12 AB3 ARG O 15 HIS O 17 5 3 HELIX 13 AB4 SER O 27 ASP O 42 1 16 HELIX 14 AB5 ASP O 48 PHE O 60 1 13 HELIX 15 AB6 ASP O 77 VAL O 81 5 5 HELIX 16 AB7 ASN O 119 ILE O 134 1 16 HELIX 17 AB8 ASP O 136 LEU O 144 1 9 HELIX 18 AB9 ASN O 147 HIS O 165 1 19 SHEET 1 AA1 4 GLN H 3 SER H 7 0 SHEET 2 AA1 4 LEU H 18 SER H 25 -1 O SER H 21 N SER H 7 SHEET 3 AA1 4 PHE H 77 MET H 82 -1 O LEU H 80 N LEU H 20 SHEET 4 AA1 4 PHE H 67 LEU H 72 -1 N SER H 70 O TYR H 79 SHEET 1 AA2 6 LEU H 11 VAL H 12 0 SHEET 2 AA2 6 THR H 107 VAL H 111 1 O THR H 110 N VAL H 12 SHEET 3 AA2 6 GLY H 88 TYR H 98 -1 N GLY H 88 O VAL H 109 SHEET 4 AA2 6 TRP H 33 GLN H 39 -1 N VAL H 37 O PHE H 91 SHEET 5 AA2 6 GLU H 46 ILE H 51 -1 O GLU H 46 N ARG H 38 SHEET 6 AA2 6 VAL H 57 TYR H 59 -1 O ASP H 58 N ARG H 50 SHEET 1 AA3 4 LEU H 11 VAL H 12 0 SHEET 2 AA3 4 THR H 107 VAL H 111 1 O THR H 110 N VAL H 12 SHEET 3 AA3 4 GLY H 88 TYR H 98 -1 N GLY H 88 O VAL H 109 SHEET 4 AA3 4 GLU H 100I TRP H 103 -1 O GLU H 100I N TYR H 98 SHEET 1 AA4 4 SER H 120 LEU H 124 0 SHEET 2 AA4 4 THR H 135 TYR H 145 -1 O LEU H 141 N PHE H 122 SHEET 3 AA4 4 TYR H 176 PRO H 185 -1 O LEU H 178 N VAL H 142 SHEET 4 AA4 4 VAL H 163 THR H 165 -1 N HIS H 164 O VAL H 181 SHEET 1 AA5 4 THR H 131 SER H 132 0 SHEET 2 AA5 4 THR H 135 TYR H 145 -1 O THR H 135 N SER H 132 SHEET 3 AA5 4 TYR H 176 PRO H 185 -1 O LEU H 178 N VAL H 142 SHEET 4 AA5 4 VAL H 169 LEU H 170 -1 N VAL H 169 O SER H 177 SHEET 1 AA6 3 THR H 151 TRP H 154 0 SHEET 2 AA6 3 TYR H 194 HIS H 200 -1 O ASN H 197 N SER H 153 SHEET 3 AA6 3 THR H 205 VAL H 211 -1 O VAL H 211 N TYR H 194 SHEET 1 AA7 4 THR L 5 GLN L 6 0 SHEET 2 AA7 4 VAL L 19 GLN L 24 -1 O GLN L 24 N THR L 5 SHEET 3 AA7 4 THR L 70 ILE L 75 -1 O ALA L 71 N CYS L 23 SHEET 4 AA7 4 PHE L 62 SER L 67 -1 N SER L 63 O THR L 74 SHEET 1 AA8 5 GLY L 9 ALA L 14 0 SHEET 2 AA8 5 THR L 102 LEU L 107 1 O LEU L 107 N VAL L 13 SHEET 3 AA8 5 ALA L 84 ARG L 91 -1 N ALA L 84 O LEU L 104 SHEET 4 AA8 5 SER L 34 LYS L 38 -1 N LYS L 38 O GLU L 85 SHEET 5 AA8 5 ILE L 45 PHE L 48 -1 O LEU L 47 N TRP L 35 SHEET 1 AA9 4 GLY L 9 ALA L 14 0 SHEET 2 AA9 4 THR L 102 LEU L 107 1 O LEU L 107 N VAL L 13 SHEET 3 AA9 4 ALA L 84 ARG L 91 -1 N ALA L 84 O LEU L 104 SHEET 4 AA9 4 SER L 96 PHE L 98 -1 O VAL L 97 N SER L 90 SHEET 1 AB1 4 SER L 115 PHE L 119 0 SHEET 2 AB1 4 ALA L 131 PHE L 140 -1 O LEU L 136 N THR L 117 SHEET 3 AB1 4 TYR L 173 LEU L 181 -1 O SER L 177 N CYS L 135 SHEET 4 AB1 4 VAL L 160 THR L 162 -1 N GLU L 161 O TYR L 178 SHEET 1 AB2 4 SER L 115 PHE L 119 0 SHEET 2 AB2 4 ALA L 131 PHE L 140 -1 O LEU L 136 N THR L 117 SHEET 3 AB2 4 TYR L 173 LEU L 181 -1 O SER L 177 N CYS L 135 SHEET 4 AB2 4 SER L 166 LYS L 167 -1 N SER L 166 O ALA L 174 SHEET 1 AB3 4 SER L 154 VAL L 156 0 SHEET 2 AB3 4 THR L 146 ALA L 151 -1 N ALA L 151 O SER L 154 SHEET 3 AB3 4 TYR L 192 HIS L 198 -1 O THR L 197 N THR L 146 SHEET 4 AB3 4 SER L 201 VAL L 207 -1 O VAL L 203 N VAL L 196 SHEET 1 AB4 5 VAL O 19 LEU O 22 0 SHEET 2 AB4 5 ALA O 85 PHE O 97 1 O ILE O 90 N LEU O 22 SHEET 3 AB4 5 VAL O 107 ALA O 116 -1 O VAL O 107 N PHE O 97 SHEET 4 AB4 5 GLY O 70 ALA O 72 1 N ALA O 72 O PHE O 113 SHEET 5 AB4 5 GLY O 63 LEU O 64 -1 N LEU O 64 O VAL O 71 SSBOND 1 CYS H 22 CYS H 92 1555 1555 2.06 SSBOND 2 CYS H 140 CYS H 196 1555 1555 2.04 SSBOND 3 CYS H 216 CYS L 212 1555 1555 2.03 SSBOND 4 CYS L 23 CYS L 88 1555 1555 2.04 SSBOND 5 CYS L 135 CYS L 194 1555 1555 2.03 CISPEP 1 PRO H 100F PRO H 100G 0 1.09 CISPEP 2 PHE H 146 PRO H 147 0 -4.08 CISPEP 3 GLU H 148 PRO H 149 0 -2.18 CISPEP 4 TYR L 141 PRO L 142 0 -0.92 SITE 1 AC1 6 LEU L 28 ARG L 29 SER L 30 HIS L 31 SITE 2 AC1 6 GLY L 68 HOH L 401 SITE 1 AC2 6 ASN H 155 ALA L 144 THR L 146 THR L 197 SITE 2 AC2 6 GLU L 199 GLY L 200 SITE 1 AC3 3 TYR H 99 ARG O 56 HIS O 75 SITE 1 AC4 6 GLY H 52C GLN L 17 GLN O 83 ASN O 84 SITE 2 AC4 6 GLY O 118 ASN O 119 CRYST1 41.404 56.596 64.196 101.75 101.19 92.17 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.024152 0.000913 0.005094 0.00000 SCALE2 0.000000 0.017682 0.003898 0.00000 SCALE3 0.000000 0.000000 0.016260 0.00000